A subcortical hemorrhage is bleeding that erupts inside the deep structures of the brain, below the outer cortex, and it accounts for the majority of spontaneous intracerebral hemorrhages. The basal ganglia, thalamus, and surrounding deep white matter are the usual sites, and chronic high blood pressure is the dominant cause. Because these deep bleeds damage tissue that relays movement, sensation, and consciousness, the consequences range from one-sided weakness to coma, and roughly a third of patients do not survive the first month.
Where Exactly the Bleeding Occurs
The term “subcortical” distinguishes bleeds that originate in the brain’s interior from “lobar” hemorrhages that start at or near the cortical surface. A widely used definition classifies hemorrhage involving the thalamus, basal ganglia, internal capsule, and deep periventricular white matter as deep (subcortical), while bleeding at the cortex or the cortical-subcortical junction counts as lobar.1JAMA Neurology. Predictors of Hematoma Volume in Deep and Lobar Supratentorial Intracerebral Hemorrhage Some classification schemes group brainstem and cerebellar hemorrhages together with deep subcortical bleeds under the umbrella of “nonlobar” hemorrhage.2JAMA Network Open. Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden
The distinction matters because these two categories tend to have different causes, different patient profiles, and different clinical courses. A Swedish population study found that deep hemorrhages carried a higher 90-day mortality rate than lobar bleeds after adjusting for hematoma size, age, and other variables.3PubMed Central. Imaging and Clinical Prognostic Features in Lobar Versus Deep Intracerebral Hemorrhage in an Unselected Swedish Population Lobar hemorrhages, by contrast, were more strongly linked to early seizures and headaches, while deep hemorrhages were more associated with hypertension, limb weakness, and sensory loss.4PubMed Central. Acute Spontaneous Lobar Cerebral Hemorrhages Present a Different Clinical Profile and a More Severe Early Prognosis than Deep Subcortical Intracerebral Hemorrhages
The Role of Small Vessel Disease
Most subcortical hemorrhages trace back to damage in the tiny penetrating arteries that supply the brain’s deep structures. These arteries branch off larger vessels at sharp angles and bear the full force of systemic blood pressure. Over years of uncontrolled hypertension, the vessel walls undergo changes that weaken them. The pathologist C. Miller Fisher described several of these changes in detail: focal bulging of the artery wall, deposits of fibrin-like material within the wall, breakdown of normal vessel layers, and replacement of healthy tissue by tangles of connective tissue. Fisher termed these processes lipohyalinosis, fibrinoid degeneration, and segmental arterial disorganization.5Journal of Stroke. Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology
The story isn’t limited to hypertension, though. Autopsy studies have found that even in people without high blood pressure, small-vessel disease can appear as a thickening of the artery walls, though the more dramatic changes like lipohyalinosis and fibrinoid necrosis are rare in the absence of hypertension.6PubMed. Nonhypertensive cerebral small-vessel disease. An autopsy study Aging itself, diabetes, and other vascular risk factors can contribute to vessel-wall damage in the deep brain, though hypertension remains by far the most potent driver.
Risk Factors and Who Gets Them
Hypertension dominates the picture. In one MRI-based study of patients with spontaneous brain bleeds, high blood pressure was present in about 88% of those with hemorrhages, compared with roughly 42% of those without. Tiny old hemorrhagic lesions visible on MRI were found in over half of hypertensive patients but only about 10% of those with normal blood pressure, and these microbleeds were most common in subcortical locations.7PubMed. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas Animal research confirms the mechanism: when blood pressure is experimentally raised, hematoma volumes grow larger, brain swelling worsens, and more cells die around the bleed.8PubMed Central. Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury
Blood-thinning medications are the second major risk factor. About 70% of anticoagulant-related intracranial hemorrhages are intracerebral, and roughly 60% of those prove fatal. Advanced age, a history of prior stroke, hypertension, and how intensely a person is anticoagulated all predict the risk.9PubMed. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses A large nationwide study found that combining anticoagulants with antiplatelet drugs raised hemorrhage risk substantially: warfarin plus aspirin and clopidogrel together, for instance, carried more than four times the risk compared to no blood thinners at all.10PLoS ONE. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs And when a hemorrhage does occur in someone on warfarin, the bleed tends to be bigger if the blood is excessively thinned: patients whose clotting measure exceeded a certain threshold had significantly larger hematomas.11PubMed Central. Warfarin use leads to larger intracerebral hematomas
Race and ethnicity also affect risk. In the United States, deep cerebral hemorrhage occurs at roughly twice the rate in Black Americans compared to White Americans, and the gap is widest in younger adults. Among people aged 35 to 54, Black individuals had about four and a half times the risk of deep hemorrhage.12PubMed. Racial variations in location and risk of intracerebral hemorrhage Multinational data further show that baseline characteristics differ by race: in one pooled analysis, White patients tended to be older and have larger hematomas, while Black patients had lower consciousness scores and higher blood pressures at presentation.13PubMed. Relationship between race and outcome in Asian, Black, and Caucasian patients with spontaneous intracerebral hemorrhage These differences likely reflect a mix of genetics, disparities in blood pressure control, access to care, and environmental factors.
What Happens After the Bleeding Starts
A brain hemorrhage is not a single event. In many patients the bleeding continues or restarts in the hours after the initial rupture. One study that tracked patients over time found that about 39% of those scanned within three hours of symptom onset had measurable growth of the blood clot, and even among those who arrived later, expansion still occurred in roughly 10-20% of cases.14PubMed Central. CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage This ongoing expansion is one of the strongest drivers of early deterioration.
Beyond the physical mass of blood, the brain suffers a second wave of injury in the days that follow. Thrombin, a protein involved in clotting, triggers inflammation and swelling in the tissue surrounding the clot. As red blood cells break down, they release iron, which is toxic to nearby neurons. These chemical cascades damage tissue that the initial bleed may have spared, which is why researchers see them as potential targets for future treatments.15PubMed. Brain injury after intracerebral hemorrhage: the role of thrombin and iron When the hemorrhage is large enough to break into the fluid-filled ventricles at the brain’s center, the blood can block the normal flow of cerebrospinal fluid, causing hydrocephalus and a dangerous rise in pressure inside the skull.16PubMed Central. Role of external ventricular drainage in the management of intraventricular hemorrhage
How Doctors Find and Image the Bleed
A CT scan is almost always the first imaging study because it is fast, widely available, and very good at showing fresh blood in the brain. Blood appears as a bright white area on CT, and the appearance evolves over days and weeks as the clot forms, retracts, and eventually dissolves.17PubMed. Intracranial hemorrhage: principles of CT and MRI interpretation For acute hemorrhage, CT and MRI perform about equally well: one head-to-head comparison found 96% agreement between the two for diagnosing a fresh bleed. MRI did pick up a few cases of hemorrhagic transformation of strokes that CT missed, and it detected more total hemorrhages overall, including older ones.18PubMed. Comparison of MRI and CT for detection of acute intracerebral hemorrhage
MRI becomes more useful once the immediate emergency has passed. Its sensitivity to the chemical changes in aging blood makes it the preferred tool for dating a hemorrhage and for spotting old microbleeds scattered through the brain, which can hint at the underlying cause. A CT angiogram, often done alongside the initial scan, can reveal a “spot sign” — a bright dot of contrast leaking into the hematoma — which predicts that the clot is likely to keep growing.
Treatment in the First Hours and Days
Lowering blood pressure aggressively is one of the first steps in the emergency department, based on the rationale that reducing the force against fragile vessels might slow ongoing bleeding. Two large trials tested this approach and found a modest signal of benefit in how patients fared overall, though neither trial met its primary goal of clearly improving functional outcomes at 90 days, and neither showed a statistically significant reduction in hematoma growth.19PubMed Central. Blood Pressure Management in Intracerebral Haemorrhage: when, how much, and for how long? Despite the ambiguity, guidelines still recommend bringing systolic blood pressure below 140 mmHg promptly when it is safe to do so, because the overall direction of evidence leans toward benefit rather than harm.
For patients on anticoagulants, reversing the blood-thinning effect as quickly as possible is critical. About half of anticoagulant-related brain bleeds enlarge gradually over 12 to 24 hours, giving doctors a window to intervene with reversal agents.20PubMed. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses When blood breaks into the ventricles and blocks fluid drainage, a tube called an external ventricular drain can be inserted to relieve the pressure.21PubMed Central. Role of external ventricular drainage in the management of intraventricular hemorrhage
The role of surgery for subcortical hemorrhage has been debated for decades. Open craniotomy to evacuate the clot has not consistently shown benefit over medical management alone for deep hemorrhages. Newer minimally invasive techniques, which use thin catheters to drain or dissolve the clot, have generated enthusiasm, but the evidence remains frustratingly mixed. The MIND trial, one of the largest randomized studies of minimally invasive surgery for intracerebral hemorrhage, found no statistically significant difference in disability at six months compared with medical care alone.22JAMA Neurology. Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage: The MIND Randomized Clinical Trial This does not necessarily mean surgery is useless for everyone — subgroups of patients with particular clot sizes or locations may still benefit — but the overall picture suggests no blanket advantage.
Predicting Who Will Recover
The biggest single predictor of how a person does after a subcortical hemorrhage is the volume of blood in the brain. Larger clots mean worse outcomes, in a dose-response fashion: a Swedish study found that hematomas of 30 to 79 milliliters more than quadrupled the risk of death at 90 days compared with smaller bleeds, and clots over 80 milliliters carried nearly six times the risk.23PubMed Central. Imaging and Clinical Prognostic Features in Lobar Versus Deep Intracerebral Hemorrhage in an Unselected Swedish Population Age, level of consciousness at arrival, hydrocephalus, and whether the brain’s midline structures have been pushed to one side all further shape the outlook.
Machine-learning models trained on large datasets have reinforced these findings. One such model identified hematoma volume as the single most important variable, with level of consciousness (measured by the Glasgow Coma Scale), white blood cell count, age, serum albumin, and systolic blood pressure rounding out the top predictors of six-month recovery.24PubMed Central. Machine learning-based prediction of 6-month functional recovery in hypertensive cerebral hemorrhage In practical terms, a small bleed in a younger person who is awake and following commands carries a far different prognosis than a large hemorrhage in an older person who arrives unconscious.
One concern in stroke neurology is that overly pessimistic predictions can become self-fulfilling. If a care team believes a patient’s chances are poor, they may limit aggressive treatment or counsel families toward comfort care, which itself reduces the chance of survival. Guidelines now emphasize avoiding premature decisions about withdrawal of care in the first 24 to 48 hours, when the picture is most uncertain.
Restarting Blood Thinners After a Brain Bleed
Patients who were on anticoagulants before their hemorrhage face an uncomfortable dilemma. They needed the blood thinners for a reason — a mechanical heart valve, atrial fibrillation, a history of blood clots — and stopping the medication indefinitely raises the risk of a stroke caused by a clot. But restarting it risks triggering another bleed in the same vulnerable brain.
The pooled evidence from retrospective studies suggests that, for most patients, restarting anticoagulation is the safer long-term bet. Resumption has been associated with lower rates of death and clot-related events without a large increase in recurrent hemorrhage.25PubMed. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage The trickier question is when. Available evidence points to a window of roughly four to six weeks after the bleed as the sweet spot that minimizes both recurrent hemorrhage and clot-related complications.
For people with mechanical heart valves, where the stakes of a clot forming on the valve are especially high, some data suggest that restarting within a week may be acceptable. A study of patients with mechanical valves and a brain hemorrhage found no difference in 30-day clot or bleed outcomes when anticoagulation was resumed within 7 days versus 7 to 30 days. Delaying beyond 30 days was associated with a higher risk of ischemic stroke.26PubMed Central. Optimal Timing for Resumption of Anticoagulation After Intracranial Hemorrhage in Patients With Mechanical Heart Valves A meta-analysis focusing on this population estimated the pooled recurrence rate of brain hemorrhage after restarting anticoagulation at about 11%, with ischemic strokes during the period the blood thinner was held at about 6%.27PubMed Central. Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients With Mechanical Valves Neither number is trivial, and the decision requires weighing the specific patient’s valve type, hemorrhage location, and overall risk profile.
When It Happens in Younger Adults
Subcortical hemorrhage is overwhelmingly a disease of middle-aged and older adults, but it does occur in younger people, and when it does, the cause is often different. Among more than 76,000 hemorrhagic stroke hospitalizations in one large database, about 5% occurred in patients under 40. These younger patients had far lower rates of hypertension and diabetes but substantially higher rates of substance use. Structural abnormalities like arteriovenous malformations and aneurysms were present in about 14% of young patients compared with under 4% of older ones, and rare conditions such as Moyamoya disease and sickle cell disease appeared at rates many times higher than in the general hemorrhage population.28PubMed Central. When Stroke Strikes Early: Unusual Causes of Intracerebral Hemorrhage in Young Adults
This means that when a younger person presents with a brain hemorrhage, doctors pursue a more extensive workup looking for underlying vascular malformations, clotting disorders, drug use (particularly stimulants), and rare genetic or inflammatory conditions. The prognosis in younger patients tends to be better on average, in part because they lack the accumulation of other medical problems that worsens outcomes in older adults, and in part because the brain retains more capacity for repair earlier in life.
Long-Term Rehabilitation and Emerging Approaches
Recovery from a subcortical hemorrhage can stretch over months to years, and the trajectory varies enormously. The motor and sensory pathways that pass through the deep brain structures are tightly packed, so even a relatively small bleed can sever connections that control movement on one side of the body, produce numbness, or impair speech. Standard rehabilitation involves physical therapy, occupational therapy, and speech therapy, started as early as the patient can safely tolerate it.
On the experimental frontier, researchers are exploring whether electrical stimulation of the brain might enhance recovery when conventional rehabilitation has plateaued. A phase I trial tested deep brain stimulation of the cerebellar dentate nucleus combined with physical rehabilitation in people who had persistent moderate-to-severe arm impairment one to three years after a stroke. The stimulation was safe, with no serious adverse events, and participants showed a meaningful improvement in arm function as measured by a standard assessment scale.29Nature Medicine. Cerebellar deep brain stimulation for chronic post-stroke motor rehabilitation: a phase I trial This is still early-stage work in a small group, but it represents a genuinely new direction: rather than just compensating for lost function, the goal is to prod the brain into reorganizing its surviving circuits.
Blood-based biomarkers are another area of active research. Proteins and other molecules released into the bloodstream after a brain hemorrhage may eventually help doctors gauge the severity of the bleed, predict who will deteriorate, and monitor recovery — all from a simple blood draw rather than repeated brain scans.30PubMed Central. Blood-Based Biomarkers in Intracerebral Hemorrhage None of these markers have entered routine clinical use yet, but the field has moved beyond proof-of-concept toward identifying which specific proteins carry the most useful information.